Építés alatt – nem éles oldal
Belépés
BefejeződöttFázis nélkül

A Clinical Trial to Evaluate the Safety and Efficacy of an Implantable Wireless Brain-Computer Interface(BCI)System NEO in Patients With Tetraplegia

A legfontosabb adatok

Ki végzi
Neuracle Medical Technology(Shanghai) Co.,Ltd.
Hol
Kína2 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Befejeződött
Résztvevők
32 fő vett részt
Kezdés
2025. máj. 28.
Befejezés
2026. jan. 10.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • NEO
A regiszteradat frissítve
2026. augusztus 25.

Ki vehet részt

Életkor
18 év – 65 év
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt
A regiszter összes feltétele (21)A regiszter feltételeinek elrejtése

Ki vehet részt

  • Age between 18 and 65 years old, no restriction on gender
  • Tetraplegia caused by cervical spinal cord injury
  • Score of ≤1 on either the ball grasp or water pouring tasks of the ARAT (Action Research Arm Test)
  • Muscle strength of finger flexors < grade 3 according to ISNCSCI (International Standards for Neurological Classification of Spinal Cord Injury)
  • Score of ≥2 for "hand to mouth" on ARAT; scores of ≥1 for both "hand to top of head" and "hand to behind the head."
  • Neurological assessment indicates normal function of the motor-related cortex, with no significant structural lesions or functional disorders identified
  • Diagnosis confirmed for at least 12 months, with a stable condition for at least 6 months following standard treatment
  • Normal cognitive function, good compliance, and voluntarily agrees to participate in the clinical trial

Ki nem vehet részt

  • Received botulinum toxin injections in the upper limb, neck, or hand within 6 months prior to enrollment, or received stem cell therapy within 1 year
  • Any unstable or significant medical condition that may interfere with study procedures or confound the evaluation of study endpoints, such as depression, mood disorders, or other cognitive impairments
  • Diagnosed with severe, unstable, and uncontrolled complex regional pain syndrome
  • Autoimmune-mediated spinal cord dysfunction/injury
  • History of other neurological disorders, such as stroke, multiple sclerosis, traumatic brain injury, or drug-resistant epilepsy
  • High risk of surgical complications, such as active systemic infection, coagulation disorders (e.g., receiving anticoagulant therapy), or platelet count below 50,000
  • Without the consent of the patient or the patient's legal guardian
  • Presence of syringomyelia, severe neuropathic pain, or severe spasticity that limits the participant's ability to engage in training
  • Requires ventilator support
  • Baclofen dosage >30 mg/day
  • Patients who have already been implanted with medical devices that deliver electrical energy to the central nervous system
  • Peripheral neuropathies (e.g. diabetic polyneuropathy, compressive neuropathies)
  • In the investigator's opinion, the study is unsafe or inappropriate for the participant, or the participant is unlikely to comply with the study follow-up schedule

Hol van ez a vizsgálat?

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

To evaluate the safety and efficacy of a Minimally Invasive Wireless Implantable Brain-Computer Interface (BCI) System NEO in patients with tetraplegia and to provide a basis for product registration.

A teljes eredeti leírásKevesebb

Through brain-computer interface alternative technology, patients can control the external equipment with brain signals to improve the patient's quality of life.

A vizsgálat csoportja

  • Treatment groupA vizsgált kezelés

    a Minimally Invasive Wireless Implantable Brain-Computer Interface (BCI) System NEO

    Kezelés: NEO

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
A Prospective, Multi-Center Clinical Trial to Evaluate the Safety and Efficacy of an Implantable Wireless Brain-Computer Interface(BCI)System NEO in Patients With Tetraplegia
A regiszteradat frissítve
2026. augusztus 25.